Evidence-based Complementary and Alternative Medicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2106831, encodeId=80402106831e4, content=第一次大修修回后系统显示一个审稿人同意，然后编辑还是给大修让润色证明，润色后提交变成pending approval.想问下大家这个是什么意思，被拒的可能性大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55b75617721, createdName=ms3000001008861272, createdTime=Tue Dec 20 16:35:05 CST 2022, time=2022-12-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107020, encodeId=d481210e02042, content=偏重的研究方向：中医药 经验分享：文章被接收了，我想更改或者添加一个通讯作者请问可以吗？会不会影响影响接收情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55b75617721, createdName=ms3000001008861272, createdTime=Thu Dec 22 08:47:55 CST 2022, time=2022-12-22, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2112384, encodeId=33642112384dc, content=循证医学中药学收稿方向, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Tue Jan 31 13:54:56 CST 2023, time=2023-01-31, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2096210, encodeId=19c9209621010, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：网药 经验分享：为什么文章online了，也没有收到交钱的邮件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c4b5247111, createdName=147d2cf7m08(暂无昵称), createdTime=Wed Oct 26 08:56:48 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109524, encodeId=fb9d2109524a8, content=请问怎么看该杂志投稿状态呢？进入之后一直显示Under review，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2Q1XIDSjrphhER6YVDSxwlREr7icvdicL0cvJO92fLwqRpniarJuicmTqickiabHPQIn3XzQlVl7FM0ClXEiaLfhNjTMw/132, createdBy=82b25278371, createdName=ms333284614918087, createdTime=Mon Jan 09 15:46:29 CST 2023, time=2023-01-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2103646, encodeId=01552103646fa, content=偏重的研究方向：网络药理学;中药复方 经验分享：10月3号投稿的，一直在 submitted～AE invited 转换。无语😓, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Thu Dec 01 08:09:15 CST 2022, time=2022-12-01, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2105688, encodeId=d54d210568894, content=投稿命中率:50.0 偏重的研究方向：动物模型;中药复方 经验分享：中药➕动物➕肾病，方向，已经投稿快两个月了，一直在ae邀请请问这个方向的前辈一般多久邀请到审稿人呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28e68389082, createdName=心想事成18, createdTime=Mon Dec 12 11:50:12 CST 2022, time=2022-12-12, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107420, encodeId=0f99210e42010, content=大修，给了3个月，但是我一个月就返修了，现在离返修已经快一个月了，还是under review,请问啥情况呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a6a5296803, createdName=ms1000001895101719, createdTime=Sun Dec 25 18:32:40 CST 2022, time=2022-12-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2106865, encodeId=e387210686527, content=偏重的研究方向：网络药理学 经验分享：想问一下submit updates阶段让上传可编辑的图片应该上传什么格式, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55b75617721, createdName=ms3000001008861272, createdTime=Tue Dec 20 21:47:55 CST 2022, time=2022-12-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1242719, encodeId=1f8b1242e19b6, content=偏重的研究方向：网络药理学;中医;中药 经验分享：问下，有没有associated editor是Chang G.Son的，速度怎么样，会不会太拖时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr123, createdTime=Fri Sep 02 06:55:18 CST 2022, time=2022-09-02, status=1, ipAttribution=)]

2022-12-20 ms3000001008861272 来自河北省

第一次大修修回后系统显示一个审稿人同意，然后编辑还是给大修让润色证明，润色后提交变成pending approval.想问下大家这个是什么意思，被拒的可能性大吗？

45 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2106831, encodeId=80402106831e4, content=第一次大修修回后系统显示一个审稿人同意，然后编辑还是给大修让润色证明，润色后提交变成pending approval.想问下大家这个是什么意思，被拒的可能性大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55b75617721, createdName=ms3000001008861272, createdTime=Tue Dec 20 16:35:05 CST 2022, time=2022-12-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107020, encodeId=d481210e02042, content=偏重的研究方向：中医药 经验分享：文章被接收了，我想更改或者添加一个通讯作者请问可以吗？会不会影响影响接收情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55b75617721, createdName=ms3000001008861272, createdTime=Thu Dec 22 08:47:55 CST 2022, time=2022-12-22, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2112384, encodeId=33642112384dc, content=循证医学中药学收稿方向, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Tue Jan 31 13:54:56 CST 2023, time=2023-01-31, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2096210, encodeId=19c9209621010, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：网药 经验分享：为什么文章online了，也没有收到交钱的邮件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c4b5247111, createdName=147d2cf7m08(暂无昵称), createdTime=Wed Oct 26 08:56:48 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109524, encodeId=fb9d2109524a8, content=请问怎么看该杂志投稿状态呢？进入之后一直显示Under review，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2Q1XIDSjrphhER6YVDSxwlREr7icvdicL0cvJO92fLwqRpniarJuicmTqickiabHPQIn3XzQlVl7FM0ClXEiaLfhNjTMw/132, createdBy=82b25278371, createdName=ms333284614918087, createdTime=Mon Jan 09 15:46:29 CST 2023, time=2023-01-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2103646, encodeId=01552103646fa, content=偏重的研究方向：网络药理学;中药复方 经验分享：10月3号投稿的，一直在 submitted～AE invited 转换。无语😓, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Thu Dec 01 08:09:15 CST 2022, time=2022-12-01, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2105688, encodeId=d54d210568894, content=投稿命中率:50.0 偏重的研究方向：动物模型;中药复方 经验分享：中药➕动物➕肾病，方向，已经投稿快两个月了，一直在ae邀请请问这个方向的前辈一般多久邀请到审稿人呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28e68389082, createdName=心想事成18, createdTime=Mon Dec 12 11:50:12 CST 2022, time=2022-12-12, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107420, encodeId=0f99210e42010, content=大修，给了3个月，但是我一个月就返修了，现在离返修已经快一个月了，还是under review,请问啥情况呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a6a5296803, createdName=ms1000001895101719, createdTime=Sun Dec 25 18:32:40 CST 2022, time=2022-12-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2106865, encodeId=e387210686527, content=偏重的研究方向：网络药理学 经验分享：想问一下submit updates阶段让上传可编辑的图片应该上传什么格式, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55b75617721, createdName=ms3000001008861272, createdTime=Tue Dec 20 21:47:55 CST 2022, time=2022-12-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1242719, encodeId=1f8b1242e19b6, content=偏重的研究方向：网络药理学;中医;中药 经验分享：问下，有没有associated editor是Chang G.Son的，速度怎么样，会不会太拖时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr123, createdTime=Fri Sep 02 06:55:18 CST 2022, time=2022-09-02, status=1, ipAttribution=)]

2022-12-22 ms3000001008861272 来自河北省

偏重的研究方向：中医药
经验分享：文章被接收了，我想更改或者添加一个通讯作者请问可以吗？会不会影响影响接收情况？

41 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2106831, encodeId=80402106831e4, content=第一次大修修回后系统显示一个审稿人同意，然后编辑还是给大修让润色证明，润色后提交变成pending approval.想问下大家这个是什么意思，被拒的可能性大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55b75617721, createdName=ms3000001008861272, createdTime=Tue Dec 20 16:35:05 CST 2022, time=2022-12-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107020, encodeId=d481210e02042, content=偏重的研究方向：中医药 经验分享：文章被接收了，我想更改或者添加一个通讯作者请问可以吗？会不会影响影响接收情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55b75617721, createdName=ms3000001008861272, createdTime=Thu Dec 22 08:47:55 CST 2022, time=2022-12-22, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2112384, encodeId=33642112384dc, content=循证医学中药学收稿方向, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Tue Jan 31 13:54:56 CST 2023, time=2023-01-31, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2096210, encodeId=19c9209621010, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：网药 经验分享：为什么文章online了，也没有收到交钱的邮件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c4b5247111, createdName=147d2cf7m08(暂无昵称), createdTime=Wed Oct 26 08:56:48 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109524, encodeId=fb9d2109524a8, content=请问怎么看该杂志投稿状态呢？进入之后一直显示Under review，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2Q1XIDSjrphhER6YVDSxwlREr7icvdicL0cvJO92fLwqRpniarJuicmTqickiabHPQIn3XzQlVl7FM0ClXEiaLfhNjTMw/132, createdBy=82b25278371, createdName=ms333284614918087, createdTime=Mon Jan 09 15:46:29 CST 2023, time=2023-01-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2103646, encodeId=01552103646fa, content=偏重的研究方向：网络药理学;中药复方 经验分享：10月3号投稿的，一直在 submitted～AE invited 转换。无语😓, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Thu Dec 01 08:09:15 CST 2022, time=2022-12-01, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2105688, encodeId=d54d210568894, content=投稿命中率:50.0 偏重的研究方向：动物模型;中药复方 经验分享：中药➕动物➕肾病，方向，已经投稿快两个月了，一直在ae邀请请问这个方向的前辈一般多久邀请到审稿人呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28e68389082, createdName=心想事成18, createdTime=Mon Dec 12 11:50:12 CST 2022, time=2022-12-12, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107420, encodeId=0f99210e42010, content=大修，给了3个月，但是我一个月就返修了，现在离返修已经快一个月了，还是under review,请问啥情况呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a6a5296803, createdName=ms1000001895101719, createdTime=Sun Dec 25 18:32:40 CST 2022, time=2022-12-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2106865, encodeId=e387210686527, content=偏重的研究方向：网络药理学 经验分享：想问一下submit updates阶段让上传可编辑的图片应该上传什么格式, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55b75617721, createdName=ms3000001008861272, createdTime=Tue Dec 20 21:47:55 CST 2022, time=2022-12-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1242719, encodeId=1f8b1242e19b6, content=偏重的研究方向：网络药理学;中医;中药 经验分享：问下，有没有associated editor是Chang G.Son的，速度怎么样，会不会太拖时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr123, createdTime=Fri Sep 02 06:55:18 CST 2022, time=2022-09-02, status=1, ipAttribution=)]

2023-01-31 ms7000000487939564 来自广西

循证医学中药学收稿方向

34 0

[GetPortalCommentsPageByObjectIdResponse(id=2106831, encodeId=80402106831e4, content=第一次大修修回后系统显示一个审稿人同意，然后编辑还是给大修让润色证明，润色后提交变成pending approval.想问下大家这个是什么意思，被拒的可能性大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55b75617721, createdName=ms3000001008861272, createdTime=Tue Dec 20 16:35:05 CST 2022, time=2022-12-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107020, encodeId=d481210e02042, content=偏重的研究方向：中医药 经验分享：文章被接收了，我想更改或者添加一个通讯作者请问可以吗？会不会影响影响接收情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55b75617721, createdName=ms3000001008861272, createdTime=Thu Dec 22 08:47:55 CST 2022, time=2022-12-22, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2112384, encodeId=33642112384dc, content=循证医学中药学收稿方向, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Tue Jan 31 13:54:56 CST 2023, time=2023-01-31, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2096210, encodeId=19c9209621010, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：网药 经验分享：为什么文章online了，也没有收到交钱的邮件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c4b5247111, createdName=147d2cf7m08(暂无昵称), createdTime=Wed Oct 26 08:56:48 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109524, encodeId=fb9d2109524a8, content=请问怎么看该杂志投稿状态呢？进入之后一直显示Under review，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2Q1XIDSjrphhER6YVDSxwlREr7icvdicL0cvJO92fLwqRpniarJuicmTqickiabHPQIn3XzQlVl7FM0ClXEiaLfhNjTMw/132, createdBy=82b25278371, createdName=ms333284614918087, createdTime=Mon Jan 09 15:46:29 CST 2023, time=2023-01-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2103646, encodeId=01552103646fa, content=偏重的研究方向：网络药理学;中药复方 经验分享：10月3号投稿的，一直在 submitted～AE invited 转换。无语😓, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Thu Dec 01 08:09:15 CST 2022, time=2022-12-01, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2105688, encodeId=d54d210568894, content=投稿命中率:50.0 偏重的研究方向：动物模型;中药复方 经验分享：中药➕动物➕肾病，方向，已经投稿快两个月了，一直在ae邀请请问这个方向的前辈一般多久邀请到审稿人呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28e68389082, createdName=心想事成18, createdTime=Mon Dec 12 11:50:12 CST 2022, time=2022-12-12, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107420, encodeId=0f99210e42010, content=大修，给了3个月，但是我一个月就返修了，现在离返修已经快一个月了，还是under review,请问啥情况呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a6a5296803, createdName=ms1000001895101719, createdTime=Sun Dec 25 18:32:40 CST 2022, time=2022-12-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2106865, encodeId=e387210686527, content=偏重的研究方向：网络药理学 经验分享：想问一下submit updates阶段让上传可编辑的图片应该上传什么格式, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55b75617721, createdName=ms3000001008861272, createdTime=Tue Dec 20 21:47:55 CST 2022, time=2022-12-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1242719, encodeId=1f8b1242e19b6, content=偏重的研究方向：网络药理学;中医;中药 经验分享：问下，有没有associated editor是Chang G.Son的，速度怎么样，会不会太拖时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr123, createdTime=Fri Sep 02 06:55:18 CST 2022, time=2022-09-02, status=1, ipAttribution=)]

2022-10-26 147d2cf7m08(暂无昵称)

审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向：网药
经验分享：为什么文章online了，也没有收到交钱的邮件？

38 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2106831, encodeId=80402106831e4, content=第一次大修修回后系统显示一个审稿人同意，然后编辑还是给大修让润色证明，润色后提交变成pending approval.想问下大家这个是什么意思，被拒的可能性大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55b75617721, createdName=ms3000001008861272, createdTime=Tue Dec 20 16:35:05 CST 2022, time=2022-12-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107020, encodeId=d481210e02042, content=偏重的研究方向：中医药 经验分享：文章被接收了，我想更改或者添加一个通讯作者请问可以吗？会不会影响影响接收情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55b75617721, createdName=ms3000001008861272, createdTime=Thu Dec 22 08:47:55 CST 2022, time=2022-12-22, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2112384, encodeId=33642112384dc, content=循证医学中药学收稿方向, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Tue Jan 31 13:54:56 CST 2023, time=2023-01-31, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2096210, encodeId=19c9209621010, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：网药 经验分享：为什么文章online了，也没有收到交钱的邮件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c4b5247111, createdName=147d2cf7m08(暂无昵称), createdTime=Wed Oct 26 08:56:48 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109524, encodeId=fb9d2109524a8, content=请问怎么看该杂志投稿状态呢？进入之后一直显示Under review，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2Q1XIDSjrphhER6YVDSxwlREr7icvdicL0cvJO92fLwqRpniarJuicmTqickiabHPQIn3XzQlVl7FM0ClXEiaLfhNjTMw/132, createdBy=82b25278371, createdName=ms333284614918087, createdTime=Mon Jan 09 15:46:29 CST 2023, time=2023-01-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2103646, encodeId=01552103646fa, content=偏重的研究方向：网络药理学;中药复方 经验分享：10月3号投稿的，一直在 submitted～AE invited 转换。无语😓, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Thu Dec 01 08:09:15 CST 2022, time=2022-12-01, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2105688, encodeId=d54d210568894, content=投稿命中率:50.0 偏重的研究方向：动物模型;中药复方 经验分享：中药➕动物➕肾病，方向，已经投稿快两个月了，一直在ae邀请请问这个方向的前辈一般多久邀请到审稿人呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28e68389082, createdName=心想事成18, createdTime=Mon Dec 12 11:50:12 CST 2022, time=2022-12-12, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107420, encodeId=0f99210e42010, content=大修，给了3个月，但是我一个月就返修了，现在离返修已经快一个月了，还是under review,请问啥情况呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a6a5296803, createdName=ms1000001895101719, createdTime=Sun Dec 25 18:32:40 CST 2022, time=2022-12-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2106865, encodeId=e387210686527, content=偏重的研究方向：网络药理学 经验分享：想问一下submit updates阶段让上传可编辑的图片应该上传什么格式, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55b75617721, createdName=ms3000001008861272, createdTime=Tue Dec 20 21:47:55 CST 2022, time=2022-12-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1242719, encodeId=1f8b1242e19b6, content=偏重的研究方向：网络药理学;中医;中药 经验分享：问下，有没有associated editor是Chang G.Son的，速度怎么样，会不会太拖时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr123, createdTime=Fri Sep 02 06:55:18 CST 2022, time=2022-09-02, status=1, ipAttribution=)]

2023-01-09 ms333284614918087 来自上海

请问怎么看该杂志投稿状态呢？进入之后一直显示Under review，正常吗？

29 0

[GetPortalCommentsPageByObjectIdResponse(id=2106831, encodeId=80402106831e4, content=第一次大修修回后系统显示一个审稿人同意，然后编辑还是给大修让润色证明，润色后提交变成pending approval.想问下大家这个是什么意思，被拒的可能性大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55b75617721, createdName=ms3000001008861272, createdTime=Tue Dec 20 16:35:05 CST 2022, time=2022-12-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107020, encodeId=d481210e02042, content=偏重的研究方向：中医药 经验分享：文章被接收了，我想更改或者添加一个通讯作者请问可以吗？会不会影响影响接收情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55b75617721, createdName=ms3000001008861272, createdTime=Thu Dec 22 08:47:55 CST 2022, time=2022-12-22, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2112384, encodeId=33642112384dc, content=循证医学中药学收稿方向, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Tue Jan 31 13:54:56 CST 2023, time=2023-01-31, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2096210, encodeId=19c9209621010, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：网药 经验分享：为什么文章online了，也没有收到交钱的邮件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c4b5247111, createdName=147d2cf7m08(暂无昵称), createdTime=Wed Oct 26 08:56:48 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109524, encodeId=fb9d2109524a8, content=请问怎么看该杂志投稿状态呢？进入之后一直显示Under review，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2Q1XIDSjrphhER6YVDSxwlREr7icvdicL0cvJO92fLwqRpniarJuicmTqickiabHPQIn3XzQlVl7FM0ClXEiaLfhNjTMw/132, createdBy=82b25278371, createdName=ms333284614918087, createdTime=Mon Jan 09 15:46:29 CST 2023, time=2023-01-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2103646, encodeId=01552103646fa, content=偏重的研究方向：网络药理学;中药复方 经验分享：10月3号投稿的，一直在 submitted～AE invited 转换。无语😓, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Thu Dec 01 08:09:15 CST 2022, time=2022-12-01, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2105688, encodeId=d54d210568894, content=投稿命中率:50.0 偏重的研究方向：动物模型;中药复方 经验分享：中药➕动物➕肾病，方向，已经投稿快两个月了，一直在ae邀请请问这个方向的前辈一般多久邀请到审稿人呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28e68389082, createdName=心想事成18, createdTime=Mon Dec 12 11:50:12 CST 2022, time=2022-12-12, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107420, encodeId=0f99210e42010, content=大修，给了3个月，但是我一个月就返修了，现在离返修已经快一个月了，还是under review,请问啥情况呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a6a5296803, createdName=ms1000001895101719, createdTime=Sun Dec 25 18:32:40 CST 2022, time=2022-12-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2106865, encodeId=e387210686527, content=偏重的研究方向：网络药理学 经验分享：想问一下submit updates阶段让上传可编辑的图片应该上传什么格式, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55b75617721, createdName=ms3000001008861272, createdTime=Tue Dec 20 21:47:55 CST 2022, time=2022-12-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1242719, encodeId=1f8b1242e19b6, content=偏重的研究方向：网络药理学;中医;中药 经验分享：问下，有没有associated editor是Chang G.Son的，速度怎么样，会不会太拖时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr123, createdTime=Fri Sep 02 06:55:18 CST 2022, time=2022-09-02, status=1, ipAttribution=)]

2022-12-01 ms4000001680289394 来自新疆

偏重的研究方向：网络药理学;中药复方
经验分享：10月3号投稿的，一直在 submitted～AE invited 转换。无语😓

36 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2106831, encodeId=80402106831e4, content=第一次大修修回后系统显示一个审稿人同意，然后编辑还是给大修让润色证明，润色后提交变成pending approval.想问下大家这个是什么意思，被拒的可能性大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55b75617721, createdName=ms3000001008861272, createdTime=Tue Dec 20 16:35:05 CST 2022, time=2022-12-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107020, encodeId=d481210e02042, content=偏重的研究方向：中医药 经验分享：文章被接收了，我想更改或者添加一个通讯作者请问可以吗？会不会影响影响接收情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55b75617721, createdName=ms3000001008861272, createdTime=Thu Dec 22 08:47:55 CST 2022, time=2022-12-22, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2112384, encodeId=33642112384dc, content=循证医学中药学收稿方向, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Tue Jan 31 13:54:56 CST 2023, time=2023-01-31, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2096210, encodeId=19c9209621010, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：网药 经验分享：为什么文章online了，也没有收到交钱的邮件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c4b5247111, createdName=147d2cf7m08(暂无昵称), createdTime=Wed Oct 26 08:56:48 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109524, encodeId=fb9d2109524a8, content=请问怎么看该杂志投稿状态呢？进入之后一直显示Under review，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2Q1XIDSjrphhER6YVDSxwlREr7icvdicL0cvJO92fLwqRpniarJuicmTqickiabHPQIn3XzQlVl7FM0ClXEiaLfhNjTMw/132, createdBy=82b25278371, createdName=ms333284614918087, createdTime=Mon Jan 09 15:46:29 CST 2023, time=2023-01-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2103646, encodeId=01552103646fa, content=偏重的研究方向：网络药理学;中药复方 经验分享：10月3号投稿的，一直在 submitted～AE invited 转换。无语😓, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Thu Dec 01 08:09:15 CST 2022, time=2022-12-01, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2105688, encodeId=d54d210568894, content=投稿命中率:50.0 偏重的研究方向：动物模型;中药复方 经验分享：中药➕动物➕肾病，方向，已经投稿快两个月了，一直在ae邀请请问这个方向的前辈一般多久邀请到审稿人呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28e68389082, createdName=心想事成18, createdTime=Mon Dec 12 11:50:12 CST 2022, time=2022-12-12, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107420, encodeId=0f99210e42010, content=大修，给了3个月，但是我一个月就返修了，现在离返修已经快一个月了，还是under review,请问啥情况呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a6a5296803, createdName=ms1000001895101719, createdTime=Sun Dec 25 18:32:40 CST 2022, time=2022-12-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2106865, encodeId=e387210686527, content=偏重的研究方向：网络药理学 经验分享：想问一下submit updates阶段让上传可编辑的图片应该上传什么格式, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55b75617721, createdName=ms3000001008861272, createdTime=Tue Dec 20 21:47:55 CST 2022, time=2022-12-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1242719, encodeId=1f8b1242e19b6, content=偏重的研究方向：网络药理学;中医;中药 经验分享：问下，有没有associated editor是Chang G.Son的，速度怎么样，会不会太拖时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr123, createdTime=Fri Sep 02 06:55:18 CST 2022, time=2022-09-02, status=1, ipAttribution=)]

2022-12-12 心想事成18 来自河北省

投稿命中率:50.0
偏重的研究方向：动物模型;中药复方
经验分享：中药➕动物➕肾病，方向，已经投稿快两个月了，一直在ae邀请请问这个方向的前辈一般多久邀请到审稿人呀

43 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2106831, encodeId=80402106831e4, content=第一次大修修回后系统显示一个审稿人同意，然后编辑还是给大修让润色证明，润色后提交变成pending approval.想问下大家这个是什么意思，被拒的可能性大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55b75617721, createdName=ms3000001008861272, createdTime=Tue Dec 20 16:35:05 CST 2022, time=2022-12-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107020, encodeId=d481210e02042, content=偏重的研究方向：中医药 经验分享：文章被接收了，我想更改或者添加一个通讯作者请问可以吗？会不会影响影响接收情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55b75617721, createdName=ms3000001008861272, createdTime=Thu Dec 22 08:47:55 CST 2022, time=2022-12-22, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2112384, encodeId=33642112384dc, content=循证医学中药学收稿方向, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Tue Jan 31 13:54:56 CST 2023, time=2023-01-31, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2096210, encodeId=19c9209621010, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：网药 经验分享：为什么文章online了，也没有收到交钱的邮件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c4b5247111, createdName=147d2cf7m08(暂无昵称), createdTime=Wed Oct 26 08:56:48 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109524, encodeId=fb9d2109524a8, content=请问怎么看该杂志投稿状态呢？进入之后一直显示Under review，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2Q1XIDSjrphhER6YVDSxwlREr7icvdicL0cvJO92fLwqRpniarJuicmTqickiabHPQIn3XzQlVl7FM0ClXEiaLfhNjTMw/132, createdBy=82b25278371, createdName=ms333284614918087, createdTime=Mon Jan 09 15:46:29 CST 2023, time=2023-01-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2103646, encodeId=01552103646fa, content=偏重的研究方向：网络药理学;中药复方 经验分享：10月3号投稿的，一直在 submitted～AE invited 转换。无语😓, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Thu Dec 01 08:09:15 CST 2022, time=2022-12-01, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2105688, encodeId=d54d210568894, content=投稿命中率:50.0 偏重的研究方向：动物模型;中药复方 经验分享：中药➕动物➕肾病，方向，已经投稿快两个月了，一直在ae邀请请问这个方向的前辈一般多久邀请到审稿人呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28e68389082, createdName=心想事成18, createdTime=Mon Dec 12 11:50:12 CST 2022, time=2022-12-12, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107420, encodeId=0f99210e42010, content=大修，给了3个月，但是我一个月就返修了，现在离返修已经快一个月了，还是under review,请问啥情况呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a6a5296803, createdName=ms1000001895101719, createdTime=Sun Dec 25 18:32:40 CST 2022, time=2022-12-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2106865, encodeId=e387210686527, content=偏重的研究方向：网络药理学 经验分享：想问一下submit updates阶段让上传可编辑的图片应该上传什么格式, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55b75617721, createdName=ms3000001008861272, createdTime=Tue Dec 20 21:47:55 CST 2022, time=2022-12-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1242719, encodeId=1f8b1242e19b6, content=偏重的研究方向：网络药理学;中医;中药 经验分享：问下，有没有associated editor是Chang G.Son的，速度怎么样，会不会太拖时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr123, createdTime=Fri Sep 02 06:55:18 CST 2022, time=2022-09-02, status=1, ipAttribution=)]

2022-12-25 ms1000001895101719 来自江西省

大修，给了3个月，但是我一个月就返修了，现在离返修已经快一个月了，还是under review,请问啥情况呀

38 0

[GetPortalCommentsPageByObjectIdResponse(id=2106831, encodeId=80402106831e4, content=第一次大修修回后系统显示一个审稿人同意，然后编辑还是给大修让润色证明，润色后提交变成pending approval.想问下大家这个是什么意思，被拒的可能性大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55b75617721, createdName=ms3000001008861272, createdTime=Tue Dec 20 16:35:05 CST 2022, time=2022-12-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107020, encodeId=d481210e02042, content=偏重的研究方向：中医药 经验分享：文章被接收了，我想更改或者添加一个通讯作者请问可以吗？会不会影响影响接收情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55b75617721, createdName=ms3000001008861272, createdTime=Thu Dec 22 08:47:55 CST 2022, time=2022-12-22, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2112384, encodeId=33642112384dc, content=循证医学中药学收稿方向, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Tue Jan 31 13:54:56 CST 2023, time=2023-01-31, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2096210, encodeId=19c9209621010, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：网药 经验分享：为什么文章online了，也没有收到交钱的邮件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c4b5247111, createdName=147d2cf7m08(暂无昵称), createdTime=Wed Oct 26 08:56:48 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109524, encodeId=fb9d2109524a8, content=请问怎么看该杂志投稿状态呢？进入之后一直显示Under review，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2Q1XIDSjrphhER6YVDSxwlREr7icvdicL0cvJO92fLwqRpniarJuicmTqickiabHPQIn3XzQlVl7FM0ClXEiaLfhNjTMw/132, createdBy=82b25278371, createdName=ms333284614918087, createdTime=Mon Jan 09 15:46:29 CST 2023, time=2023-01-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2103646, encodeId=01552103646fa, content=偏重的研究方向：网络药理学;中药复方 经验分享：10月3号投稿的，一直在 submitted～AE invited 转换。无语😓, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Thu Dec 01 08:09:15 CST 2022, time=2022-12-01, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2105688, encodeId=d54d210568894, content=投稿命中率:50.0 偏重的研究方向：动物模型;中药复方 经验分享：中药➕动物➕肾病，方向，已经投稿快两个月了，一直在ae邀请请问这个方向的前辈一般多久邀请到审稿人呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28e68389082, createdName=心想事成18, createdTime=Mon Dec 12 11:50:12 CST 2022, time=2022-12-12, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107420, encodeId=0f99210e42010, content=大修，给了3个月，但是我一个月就返修了，现在离返修已经快一个月了，还是under review,请问啥情况呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a6a5296803, createdName=ms1000001895101719, createdTime=Sun Dec 25 18:32:40 CST 2022, time=2022-12-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2106865, encodeId=e387210686527, content=偏重的研究方向：网络药理学 经验分享：想问一下submit updates阶段让上传可编辑的图片应该上传什么格式, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55b75617721, createdName=ms3000001008861272, createdTime=Tue Dec 20 21:47:55 CST 2022, time=2022-12-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1242719, encodeId=1f8b1242e19b6, content=偏重的研究方向：网络药理学;中医;中药 经验分享：问下，有没有associated editor是Chang G.Son的，速度怎么样，会不会太拖时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr123, createdTime=Fri Sep 02 06:55:18 CST 2022, time=2022-09-02, status=1, ipAttribution=)]

2022-12-20 ms3000001008861272 来自河北省

偏重的研究方向：网络药理学
经验分享：想问一下submit updates阶段让上传可编辑的图片应该上传什么格式

45 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2106831, encodeId=80402106831e4, content=第一次大修修回后系统显示一个审稿人同意，然后编辑还是给大修让润色证明，润色后提交变成pending approval.想问下大家这个是什么意思，被拒的可能性大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55b75617721, createdName=ms3000001008861272, createdTime=Tue Dec 20 16:35:05 CST 2022, time=2022-12-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107020, encodeId=d481210e02042, content=偏重的研究方向：中医药 经验分享：文章被接收了，我想更改或者添加一个通讯作者请问可以吗？会不会影响影响接收情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55b75617721, createdName=ms3000001008861272, createdTime=Thu Dec 22 08:47:55 CST 2022, time=2022-12-22, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2112384, encodeId=33642112384dc, content=循证医学中药学收稿方向, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231016/53cff9b079564f53b317b41528a4f4f9/0afbde233d144644821179baf45dc28a.jpg, createdBy=6f2e8521059, createdName=ms7000000487939564, createdTime=Tue Jan 31 13:54:56 CST 2023, time=2023-01-31, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2096210, encodeId=19c9209621010, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：网药 经验分享：为什么文章online了，也没有收到交钱的邮件？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c4b5247111, createdName=147d2cf7m08(暂无昵称), createdTime=Wed Oct 26 08:56:48 CST 2022, time=2022-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109524, encodeId=fb9d2109524a8, content=请问怎么看该杂志投稿状态呢？进入之后一直显示Under review，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/2Q1XIDSjrphhER6YVDSxwlREr7icvdicL0cvJO92fLwqRpniarJuicmTqickiabHPQIn3XzQlVl7FM0ClXEiaLfhNjTMw/132, createdBy=82b25278371, createdName=ms333284614918087, createdTime=Mon Jan 09 15:46:29 CST 2023, time=2023-01-09, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2103646, encodeId=01552103646fa, content=偏重的研究方向：网络药理学;中药复方 经验分享：10月3号投稿的，一直在 submitted～AE invited 转换。无语😓, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=07dc5590988, createdName=ms4000001680289394, createdTime=Thu Dec 01 08:09:15 CST 2022, time=2022-12-01, status=1, ipAttribution=新疆), GetPortalCommentsPageByObjectIdResponse(id=2105688, encodeId=d54d210568894, content=投稿命中率:50.0 偏重的研究方向：动物模型;中药复方 经验分享：中药➕动物➕肾病，方向，已经投稿快两个月了，一直在ae邀请请问这个方向的前辈一般多久邀请到审稿人呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=28e68389082, createdName=心想事成18, createdTime=Mon Dec 12 11:50:12 CST 2022, time=2022-12-12, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2107420, encodeId=0f99210e42010, content=大修，给了3个月，但是我一个月就返修了，现在离返修已经快一个月了，还是under review,请问啥情况呀 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a6a5296803, createdName=ms1000001895101719, createdTime=Sun Dec 25 18:32:40 CST 2022, time=2022-12-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2106865, encodeId=e387210686527, content=偏重的研究方向：网络药理学 经验分享：想问一下submit updates阶段让上传可编辑的图片应该上传什么格式, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55b75617721, createdName=ms3000001008861272, createdTime=Tue Dec 20 21:47:55 CST 2022, time=2022-12-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1242719, encodeId=1f8b1242e19b6, content=偏重的研究方向：网络药理学;中医;中药 经验分享：问下，有没有associated editor是Chang G.Son的，速度怎么样，会不会太拖时间？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRlaNsibBfeuA0EW7Q5OWSkTWOHz1DiblLt8PaWHctok4KpNWSjS3icIT1pVWV7cyaSmsjV7DpO7G9nE/0, createdBy=ee2f1951550, createdName=Dr123, createdTime=Fri Sep 02 06:55:18 CST 2022, time=2022-09-02, status=1, ipAttribution=)]

2022-09-02 Dr123

偏重的研究方向：网络药理学;中医;中药
经验分享：问下，有没有associated editor是Chang G.Son的，速度怎么样，会不会太拖时间？

50 9

展开9条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务